Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)

PHASE2CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

September 23, 2021

Conditions
Primary Sjogren Syndrome
Interventions
BIOLOGICAL

VAY736

VAY736

OTHER

Placebo

Placebo control

Trial Locations (56)

1070

Novartis Investigative Site, Brussels

1117

Novartis Investigative Site, CABA

3000

Novartis Investigative Site, Leuven

5000

Novartis Investigative Site, Córdoba

6720

Novartis Investigative Site, Szeged

8036

Novartis Investigative Site, Graz

11490

Novartis Investigative Site, Taipei

13353

Novartis Investigative Site, Berlin

14618

AAIR Research Center, Rochester

15090

Advanced Rheumatology and Arthritis Wellness Center, Wexford

15213

UPMC, Pittsburgh

20089

Novartis Investigative Site, Rozzano

21224

The John Hopkins Jerome L Greene Sjogren, Baltimore

29200

Novartis Investigative Site, Brest

33100

Novartis Investigative Site, Udine

33324

Integral Rheumatology and Immunology Specialists IRIS, Plantation

36200

Novartis Investigative Site, Vigo

38320

Novartis Investigative Site, San Cristóbal de La Laguna

40447

Novartis Investigative Site, Taichung

46202

Indiana Univ School of Dentistry, Indianapolis

52621

Novartis Investigative Site, Ramat Gan

59037

Novartis Investigative Site, Lille

77030

Baylor College Of Medicine, Houston

78229

First Outpatient Research Unit, San Antonio

79106

Novartis Investigative Site, Freiburg im Breisgau

81346

Novartis Investigative Site, Kaohsiung City

81377

Novartis Investigative Site, München

97080

Novartis Investigative Site, Würzburg

115522

Novartis Investigative Site, Moscow

195257

Novartis Investigative Site, Saint Petersburg

400006

Novartis Investigative Site, Cluj-Napoca

407219

Novartis Investigative Site, Taichung

460000

Novartis Investigative Site, Orenburg

500283

Novartis Investigative Site, Brasov

620028

Novartis Investigative Site, Yekaterinburg

7500710

Novartis Investigative Site, Santiago

8207257

Novartis Investigative Site, Santiago

02111

Tufts School of Dental Medicine, Boston

C1055AAF

Novartis Investigative Site, Ciudad Autonoma de Bs As

X5016KEH

Novartis Investigative Site, Córdoba

H-1097

Novartis Investigative Site, Budapest

00161

Novartis Investigative Site, Roma

457 8510

Novartis Investigative Site, Nagoya

857-1165

Novartis Investigative Site, Sasebo

173-8610

Novartis Investigative Site, Itabashi-ku

160 8582

Novartis Investigative Site, Shinjuku-ku

3015 GD

Novartis Investigative Site, Rotterdam

20-954

Novartis Investigative Site, Lublin

2801 951

Novartis Investigative Site, Almada

1050-034

Novartis Investigative Site, Lisbon

1649 035

Novartis Investigative Site, Lisbon

4099-001

Novartis Investigative Site, Porto

08041

Novartis Investigative Site, Barcelona

B15 2TH

Novartis Investigative Site, Birmingham

L9 7AL

Novartis Investigative Site, Liverpool

SSO 0RY

Novartis Investigative Site, Southend

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY